Target immune cells of BiTEs could be varied based on the Horn, et al. finding that BiTEs could activate CD4 positive T cells, CD8 positive T cells, and NKT cells obtained from a healthy donor to promote specific lysis on PD-L1 positive tumor cells15. The gene discussed is CD8A; the disease is neoplasm.